Skip to content
The Nexus
DossierENTITY

Pluvicto

Coverage of Pluvicto in the Nexus archive.

Earliest in view: Jun 2 · 15:04 UTCMost recent: Jun 2 · 15:04 UTC
Co-mentioned in this coverage
Vera Therapeuticsorganization1FDAorganization1Abivaxorganization1atacicepttopic1IgA nephropathytopic1ulcerative colitistopic1cancertopic1
Recent coverage
  • HEALTHJun 2 · 15:04 UTCSTAT NEWS
    STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting

    A radiopharmaceutical shows promise in the post-Pluvicto setting. Vera Therapeutics and the FDA agreed to accelerate analysis of a Phase 3 study for atacicept in treating IgA nephropathy, while Abivax reported positive data for an ulcerative colitis treatment despite cancer concerns.

Pluvicto · Dossier · The Nexus